G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 29,100
-2,200 (-7.03%)
At close: Jul 20, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 481.47 billion as of July 20, 2026.
Market Cap
481.47B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29,100.00
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has decreased from 503.30B to 481.47B, a decrease of -4.34%. That is a compound annual growth rate of -4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 481.47B | -56.24% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 282.02B |
| ImmuneOncia Therapeutics | 257.84B |
| NOVAREX | 221.39B |
| CellBion | 170.48B |
| DAE HWA Pharmaceutical | 162.90B |
| Cosmax Nbt | 162.79B |
| GC WellBeing | 145.27B |
| Vivozon Pharmaceutical | 143.49B |